<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<doc>
  <docno>
    <textblock>FR940214-1-00043</textblock>
  </docno>
  <parent>
    <textblock>FR940214-1-00009</textblock>
  </parent>
  <text>
    <textblock>(ii) Required water quality requirements are those</textblock>
    <textblock>listed in sections 3.2.1, Water Bacteriology; 3.2.2, Maximum</textblock>
    <textblock>Level of Chemical Contaminants; and in Appendix B:</textblock>
    <textblock>Guideline for Monitoring Purity of Water Used for</textblock>
    <textblock>Hemodialysis as B1 through B5.</textblock>
    <textblock>(iii) Incorporation by reference of the Association for</textblock>
    <textblock>the Advancement of Medical Instrumentation's ``Hemodialysis</textblock>
    <textblock>Systems'' (2nd edition) (ANSI/AAMI RD5-1992) was approved by</textblock>
    <textblock>the Director of the Federal Register in accordance with 5</textblock>
    <textblock>U.S.C. 552(a) and 1 CFR part 51. This publication is</textblock>
    <textblock>available for inspection at the HCFA Information Resource</textblock>
    <textblock>Center, 6325 Security Boulevard, Room G-10-A East High Rise</textblock>
    <textblock>Building, Baltimore, MD 21207 and the Office of the Federal</textblock>
    <textblock>Register, 800 North Capitol Street, NW., suite 700,</textblock>
    <textblock>Washington, DC. Copies may be purchased from AAMI, 3300</textblock>
    <textblock>Washington Boulevard, suite 400, Arlington, VA 22201-4598.</textblock>
    <textblock>If any changes in ``Hemodialysis Systems'' (2nd edition) are</textblock>
    <textblock>also to be incorporated by reference, a document to that</textblock>
    <textblock>effect will be published in the</textblock>
    <textblock>Federal Register</textblock>
    <textblock>.</textblock>
    <textblock>* * * * *</textblock>
    <textblock>C. In §405.2150, the undesignated introductory text</textblock>
    <textblock>and paragraph (a) are revised, paragraph (b) is removed,</textblock>
    <textblock>paragraphs (c) and (d) are redesignated as paragraphs (b)</textblock>
    <textblock>and (c), respectively, and redesignated paragraph (c)(1) is</textblock>
    <textblock>revised to read as follows:</textblock>
    <textblock>§405.2150</textblock>
    <textblock>Condition: Reuse of hemodialyzers and other</textblock>
    <textblock>dialysis supplies.</textblock>
    <textblock>An ESRD facility that reuses hemodialyzers and other</textblock>
    <textblock>dialysis supplies meets the requirements of this section.</textblock>
    <textblock>Failure to meet any of paragraphs (a) through (c) of this section</textblock>
    <textblock>constitutes grounds for denial of payment for the dialysis</textblock>
    <textblock>treatment affected and termination from participation in the</textblock>
    <textblock>Medicare program.</textblock>
    <textblock>(a)</textblock>
    <textblock>Standard: Hemodialyzers.</textblock>
    <textblock>If the ESRD facility</textblock>
    <textblock>reuses hemodialyzers, it conforms to the following:</textblock>
    <textblock>(1)</textblock>
    <textblock>Reuse guidelines.</textblock>
    <textblock>Voluntary guidelines adopted by</textblock>
    <textblock>the Association for the Advancement of Medical</textblock>
    <textblock>Instrumentation (A.A.M.I.) 1993 edition (i.e., ``Recommended</textblock>
    <textblock>Practice for Reuse of Hemodialyzers''). Incorporation by</textblock>
    <textblock>reference of the Association for the Advancement of Medical</textblock>
    <textblock>Instrumentation 1993 edition of the ``Recommended Practice</textblock>
    <textblock>for Reuse of Hemodialyzers'' (ANSI/AAMI RD47) was approved by</textblock>
    <textblock>the Director of the Federal Register in accordance with 5</textblock>
    <textblock>U.S.C. 552(a) and 1 CFR part 51. This publication is</textblock>
    <textblock>available for inspection at the HCFA Information Resource</textblock>
    <textblock>Center, 6325 Security Boulevard, Room G-10-A East High Rise Building, Baltimore, MD 21207 and the Office of the Federal</textblock>
    <textblock>Register, 800 North Capitol Street, NW., suite 700,</textblock>
    <textblock>Washington, DC. Copies may be purchased from AAMI, 3300</textblock>
    <textblock>Washington Boulevard, Suite 400, Arlington, VA 22201-4598.</textblock>
    <textblock>If any changes in the ``Recommended Practice for Reuse of</textblock>
    <textblock>Hemodialyzers'' are also to be incorporated by reference, a</textblock>
    <textblock>document to that effect will be published in the</textblock>
    <textblock>Federal</textblock>
    <textblock>Register.</textblock>
    <textblock>(2)</textblock>
    <textblock>Procedure for chemical germicides.</textblock>
    <textblock>To prevent any</textblock>
    <textblock>risk of dialyzer membrane leaks due to the combined action</textblock>
    <textblock>of different chemical germicides, dialyzers are exposed to</textblock>
    <textblock>only one chemical germicide during the reprocessing</textblock>
    <textblock>procedure. If a dialyzer is exposed to a second germicide,</textblock>
    <textblock>the dialyzer must be discarded.</textblock>
    <textblock>(3)</textblock>
    <textblock>Surveillance of patient reactions.</textblock>
    <textblock>In order to</textblock>
    <textblock>detect bacteremia and to maintain patient safety when</textblock>
    <textblock>unexplained events occur, the facility_</textblock>
    <textblock>(i) Takes appropriate blood cultures at the time of a</textblock>
    <textblock>febrile response in a patient; and</textblock>
    <textblock>(ii) If pyrogenic reactions, bacteremia, or unexplained</textblock>
    <textblock>reactions associated with ineffective reprocessing are</textblock>
    <textblock>identified, terminates reuse of hemodialyzers in that setting and does not continue reuse until the entire</textblock>
    <textblock>reprocessing system has been evaluated.</textblock>
    <textblock>(b) *␣*␣*</textblock>
    <textblock>(c) *␣*␣*</textblock>
    <textblock>(1) Limit the reuse of bloodlines to the same patient;</textblock>
    <textblock>* * * * *</textblock>
    <textblock>(Catalog of Federal Domestic Assistance Program No. 93.773,</textblock>
    <textblock>Medicare_Hospital Insurance; and Program No. 93.774,</textblock>
    <textblock>Medicare_Supplementary Medical Insurance Program)</textblock>
    <textblock>Dated: September 23, 1993.</textblock>
  </text>
  <signer>
    <textblock>Bruce C. Vladeck,</textblock>
  </signer>
  <signjob>
    <textblock>Administrator, Health Care</textblock>
    <textblock>Financing Administration.</textblock>
    <textblock>Dated: October 23, 1993.</textblock>
  </signjob>
  <signer>
    <textblock>Donna E. Shalala,</textblock>
  </signer>
  <signjob>
    <textblock>Secretary.</textblock>
  </signjob>
  <frfiling>
    <textblock>[FR Doc. 94-3307 Filed 2-11-94; 8:45 am]</textblock>
  </frfiling>
  <billing>
    <textblock>BILLING CODE 4120-01-P</textblock>
  </billing>
</doc>
